Latest Loan Facilities News

Paladin Energy completes Langer Heinrich Mine ramp-up, delivering strong FY2026 results and advancing its Canadian PLS Project with a new uranium discovery. FY2027 guidance forecasts stable production and costs amid ongoing regulatory progress.

Entropy Neurodynamics has reported breakthrough Phase 2 clinical results for its intravenous psilocin therapy in treatment-resistant Binge Eating Disorder, alongside strong Phase 2a data in Irritable Bowel Syndrome and a new US patent filing.

Babylon Pump & Power has initiated a $12.7 million rights issue at a 37.5% discount to restore working capital, reduce debt, and expand its water management rental fleet, aiming to lift its ASX trading suspension.

CONNEQT Health's June quarter saw record consumer revenue growth and a 70% jump in enterprise subscription ARR, supported by a $5.5 million placement and progress on its FDA regulatory pathway for its cloud-based vascular analytics platform.

Canterbury Resources is pushing ahead with a large-scale drilling program at its Briggs Copper Project while integrating its newly acquired Monto Project, setting the stage for a Pre-Feasibility Study on a potential tier-one copper operation.

XPON Technologies delivered a positive unaudited Group EBITDA of $1.1 million for FY26, supported by strategic divestments and a focus on its AI marketing platform Wondaris. The company improved gross margins and maintained strong customer retention despite divesting non-core businesses.

Minbos Resources has secured A$4 million in a discounted placement to fund key milestones at its Cabinda Phosphate Project, including mining commencement and plant construction progress.

ECS Botanics delivered a fourth consecutive quarter of positive operating cash flow in Q4 FY26, with a full-year turnaround of $5.9 million. The company’s branded B2C revenue surged 31% year-on-year, supported by product launches and European market expansion.

Wingara AG appoints Christopher Hood as CEO, aiming to boost its hay trading and agricultural logistics business with a significant equity-linked remuneration package.

Dimerix has acquired DMX-652, a Phase 2-ready oral drug candidate targeting acute kidney injury, expanding its renal disease portfolio. The acquisition includes patent rights, an FDA-approved trial protocol, and funding to initiate clinical development.

Keybridge Capital Limited confirms ongoing financial support from WAM Active and outlines plans to meet overdue reporting obligations ahead of a potential ASX delisting.

Babylon Pump & Power has secured $0.4 million in convertible loans from key shareholders and plans a $12.7 million rights issue at a 35% discount to address working capital shortfalls and reduce debt.